Objects
Teng, Christina, Reuter, Stephanie E., Blinman, Prunella L., Dhillon, Haryana M., Galettis, Peter, Proschogo, Nicholas, McLachlan, Andrew J., Vardy, Janette L.. Springer; 2020. Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.
Majimbi, Maimuna, Brook, Emily, Galettis, Peter, Eden, Edward, Al-Salami, Hani, Mooranian, Armin, Al-Sallami, Hesham, Lam, Virginie, Mamo, John C. L., Takechi, Ryusuke. Public Library of Science; 2021. Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid.
Harris, Benjamin D. W., Phan, Viet, Perera, Vidya, Szyc, Anneliese, Galettis, Peter, Martin, Jennifer H., Walpole, Euan, McLachlan, Andrew J., Clarke, Stephen J., Reuter, Stephanie E., Charles, Kellie A.. Adis International; 2020. Inability of current dosing to achieve carboplatin therapeutic targets in people with advanced non-small cell lung cancer: impact of systemic inflammation on carboplatin exposure and clinical outcomes.
Bonomo, Yvonne, Norman, Amanda, Collins, Lisa, O’Neill, Helen, Galettis, Peter, Trinca, Jane, Strauss, Nigel, Martin, Jennifer, Castle, David. Adis International; 2022. Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study.
Solowij, Nadia, Broyd, Samantha J., Croft, Rodney J., Martin, Jennifer H., Yücel, Murat, Beale, Camilla, Prick, Julie-Anne, Greenwood, Lisa-Marie, van Hell, Hendrika, Suo, Chao, Galettis, Peter, Pai, Nagesh, Fu, Shanlin. Mary Ann Liebert; 2018. Therapeutic effects of prolonged cannabidiol treatment on psychological symptoms and cognitive function in regular cannabis users: a pragmatic open-label clinical trial.
Solowij, Nadia, Broyd, Samantha, Murray, Robin, Jones, Alison, Michie, Patricia T., Croft, Rodney, Greenwood, Lisa-Marie, van Hell, Hendrika, Martelozzo, Dave, Rueb, Kuna, Todd, Juanita, Liu, Zheng, Galettis, Peter, Martin, Jennifer. Springer; 2019. A randomised controlled trial of vaporised Δ⁹-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
Tong, Ziqiu, Esser, Lars, Voelcker, Nicolas H., Galettis, Peter, Rudd, David, Easton, Christopher D., Nilghaz, Azadeh, Peng, Bo, Zhu, Douer, Thissen, Helmut, Martin, Jennifer H.. MDPI AG; 2023. Fluoropolymer Functionalization of Organ-on-Chip Platform Increases Detection Sensitivity for Cannabinoids.
Shortt, Jake, Galettis, Peter, Cheah, Chan Y., Davis, Joanne, Ludford-Menting, Mandy, Link, Emma K, Martin, Jennifer H., Koldej, Rachel, Ritchie, David. BioMed Central (BMC); 2023. A Phase 1 Clinical Trial of the Repurposable Acetyllysine Mimetic, n-methyl-2-pyrrolidone (NMP), in Relapsed or Refractory Multiple Myeloma.
Campbell, Erin J., Bonomo, Yvonne, Pastor, Adam, Collins, Lisa, Norman, Amanda, Galettis, Peter, Johnstone, Janice, Lawrence, Andrew J.. John Wiley & Sons; 2021. The 5-HT<sub>2C</sub> receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment-seeking individuals..
Liu, Zheng, Galettis, Peter, Broyd, Samantha J., van Hell, Hendrika, Greenwood, Lisa-Marie, de Krey, Peter, Steigler, Amy, Zhu, Xiao, Schneider, Jennifer, Solowij, Nadia, Martin, Jennifer H.. Wiley-Blackwell; 2020. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.